UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                               Amendment No. 1 to
                                  Form 10-QSB

     (Mark  One)
(X)  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURTIES  EXCHANGE  ACT  OF  1934

For  the  quarterly  period  ended  December  31,  2003
                                    --------------------

( )  TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934

For  the  transition  period  from                   to
                                    ---------------      ----------------
                        COMMISSION FILE NUMBER 0-30711
                        --------------------------------

                            SECURITY BIOMETRICS, INC.
    -----------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

           Nevada                                            98-0209119
--------------------------------                    ----------------------------
 State  or other  jurisdiction                      (IRS Employer Identification
of incorporation or organization                                No.)


         500 5th Avenue, Suite 1650  New York, NY  10110
  ----------------------------------------------------------------------------
                    (Address of principal executive offices)

Issuer's  telephone  number:  (212)  931-5760
                              ---------------

State the number of shares outstanding of each of the issuer's classes of common
stock  as  of  December  31,  2003

Common  Stock,  $.001  par  value                      142,008,007
---------------------------------                  ------------------
             Class                                 Number  of  shares


<PAGE>


                        SECURITY  BIOMETRICS,  INC.

                                 INDEX
                                 -----


PART  I

Item  1
Financial  Information                                      Page  No.
-----------------------------------------------------      -----------

Consolidated  Balance  Sheet  December  31,  2003 . . . . . . .3-4

Consolidated  Statement of Comprehensive Loss for
the six and three month period ended  December  31,
2003  &  2002 . . . . . . . . . . . . . . . . . . . .. . . . .   5

Consolidated Statement of Operations for the six
and three months ended December 31,  2003  &  2002. . . . . . .  6

Consolidated  Statement  of  Stockholders'  Equity
for  the  six  months  ended  December  31,  2003 . . . . . . .  7

Consolidated  Statement  of  Cash  Flows  for  the
six and three months ended December 31, 2003 & 2002 . . . . . .8-9

Notes  to  Consolidated  Financial  Statements for
the period ended December 31, 2003. .. . . . . . . . . . . . .10-19

Item  2.
Management Discussion and Analysis of Results of
 Operations  and  Financial  Condition. . . . . . . . . . . .20-22

Item  3.
Controls  and  Procedures.

PART  II

Item  1.
Legal  proceedings

Item  2.
Changes  in  Securities

Item  3.
Default  on  Senior  Securities

Item  4.
Submission of matters to a vote of security holders

Item  5.
Other  information

Item  6
Exhibits  and  reports  on  8-K

Signatures

                                        2
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET
(Unaudited)
<TABLE>
<CAPTION>



                                              DECEMBER 31,    JUNE 30,
                                                  2003          2003
<S>                                          <C>             <C>
CURRENT ASSETS
Cash and cash equivalents . . . . . . . . .  $    1,595,294  $    4,092
Accounts receivable . . . . . . . . . . . .          15,132      94,634
Inventory . . . . . . . . . . . . . . . . .           7,769           -
Prepaid expenses and other assets . . . . .          53,795      19,064
Current assets of discontinued operations .               -     137,270
                                             --------------  ----------
                                                  1,671,990     255,060
PROPERTY AND EQUIPMENT, NET OF ACCUMULATED
 DEPRECIATION . . . . . . . . . . . . . . .          63,409      65,018

LONG-TERM ASSETS OF DISCONTINUED OPERATIONS               -      23,783
                                             --------------  ----------
                                             $    1,735,399  $  343,861
                                             ==============  ==========
</TABLE>


                                        3
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET  (CONTINUED)
(Unaudited)
<TABLE>
<CAPTION>

                                                                 DECEMBER 31,       JUNE 30,
                                                                     2003             2003
<S>                                                             <C>              <C>
CURRENT LIABILITIES
Accounts payable and accrued liabilities - non-related parties  $    1,055,113   $      686,762
Accounts payable and accrued liabilities - related parties . .       1,053,041        1,540,704
Billings in excess of costs and estimated earnings on. . . . .       1,755,270                -
 uncompleted contracts
Corporate income taxes payable . . . . . . . . . . . . . . . .         424,542          424,542
Capital lease payable. . . . . . . . . . . . . . . . . . . . .           3,487            5,230
Notes payable. . . . . . . . . . . . . . . . . . . . . . . . .       1,919,107        2,000,000
Convertible debentures . . . . . . . . . . . . . . . . . . . .       1,680,000        1,780,000
Current liabilities of discontinued operations . . . . . . . .               -          719,955
                                                                ---------------  ---------------
TOTAL CURRENT LIABILITIES. . . . . . . . . . . . . . . . . . .       7,890,560        7,157,193
                                                                ---------------  ---------------
LONG-TERM LIABILITIES
Capital lease - long term portion. . . . . . . . . . . . . . .               -              872
Minority interest in equity of consolidated subsidiary . . . .             121              193
                                                                ---------------  ---------------
TOTAL LONG-TERM LIABILITIES. . . . . . . . . . . . . . . . . .             121            1,065
                                                                ---------------  ---------------

STOCKHOLDERS' DEFICIENCY
COMMON STOCK
Authorized - 300,000,000 shares $0.001 par value
Issued and outstanding 142,008,007 shares. . . . . . . . . . .         142,008          124,296
Additional paid-in capital . . . . . . . . . . . . . . . . . .       9,606,481        8,201,508
Accumulated other comprehensive loss . . . . . . . . . . . . .        (  6,453)        (  5,247)
Accumulated deficit. . . . . . . . . . . . . . . . . . . . . .   (  15,897,318)   (  15,134,954)
                                                                ---------------  ---------------
TOTAL STOCKHOLDERS' DEFICIENCY . . . . . . . . . . . . . . . .    (  6,155,282)    (  6,814,397)
                                                                ---------------  ---------------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY . . . . . . . .  $    1,735,399   $      343,861
                                                                ===============  ===============
</TABLE>



                                        4
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  COMPREHENSIVE  LOSS
(UNAUDITED)

<TABLE>
<CAPTION>
                                         SIX MONTHS ENDED                   THREE MONTHS ENDED
                                            DECEMBER 31,                       DECEMBER 31,
                                     2003                 2002              2003          2002
                              ------------------  --------------------  ------------  ------------
<S>                           <C>                 <C>                   <C>           <C>
NET LOSS . . . . . . . . . .  $      (  762,364)  $        (  872,136)  $(  441,287)  $(  668,334)
OTHER COMPREHENSIVE LOSS
Foreign currency translation           (  1,206)                6,366             -         5,546
 adjustment
                              ------------------  --------------------  ------------  ------------
COMPREHENSIVE LOSS . . . . .  $      (  763,570)  $        (  865,770)  $(  441,287)  $(  662,788)
                              ==================  ====================  ============  ============

</TABLE>


                                        5
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  OPERATIONS
(Unaudited)

<TABLE>
<CAPTION>
                                                               SIX MONTHS ENDED                    THREE MONTHS ENDED
                                                                  DECEMBER 31,                         DECEMBER 31,
                                                            2003                 2002              2003           2002
                                                     ------------------  --------------------  -------------  -------------
<S>                                                  <C>                 <C>                   <C>            <C>
REVENUE
Contract revenues earned. . . . . . . . . . . . . .  $       1,707,224   $           963,673   $  1,548,524   $    286,139
Other revenues. . . . . . . . . . . . . . . . . . .             12,067                     -              -              -
TOTAL REVENUE . . . . . . . . . . . . . . . . . . .          1,719,291               963,673      1,548,524        286,139
                                                     ------------------  --------------------

COSTS AND EXPENSES
Cost of revenues earned . . . . . . . . . . . . . .            968,654               444,745        891,543        243,783
Interest expense. . . . . . . . . . . . . . . . . .            377,098               206,908        286,909        111,613
Selling, general and administrative . . . . . . . .          1,380,975               949,226        696,498        461,471
Penalty on convertible debenture. . . . . . . . . .            150,000                              150,000
Gain on settlement of debt. . . . . . . . . . . . .            (35,139)                             (35,139)
                                                     ------------------  --------------------  -------------  -------------
TOTAL COSTS AND EXPENSES. . . . . . . . . . . . . .          2,841,588             1,600,879      1,989,811        816,867)
LOSS FROM CONTINUING OPERATIONS . . . . . . . . . .       (  1,122,297)             (637,206)      (441,287)      (530,728)
                                                     ------------------  --------------------  -------------  -------------

OTHER ITEM
Income (loss) from discontinued . . . . . . . . . .            359,933            (  234,930)             -     (  155,606)
 operations
                                                     ------------------  --------------------  -------------  -------------
NET LOSS. . . . . . . . . . . . . . . . . . . . . .  $      (  762,364)  $        (  872,136)  $ (  441,287)  $ (  686,334)
                                                     ==================  ====================  =============  =============

NET LOSS PER COMMON SHARE . . . . . . . . . . . . .  $         (  0.01)  $           (  0.01)  $    (  0.00)  $    (  0.00)
Basic and diluted
                                                     ==================  ====================  =============  =============
WEIGHTED AVERAGE NUMBER OF COMMON STOCK OUTSTANDING        128,358,289           119,502,841    136,532,888    120,131,602
Basic and diluted
                                                     ==================  ====================  =============  =============
</TABLE>


                                        6
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  STOCKHOLDERS'  EQUITY
(Unaudited)
<TABLE>
<CAPTION>

                                                                      ACCUMULATED
                                                       ADDITIONAL        OTHER
                                   COMMON STOCK          PAID IN     COMPREHENSIVE    ACCUMULATED
                             ----------------------
                                SHARES      AMOUNT      CAPITAL          LOSS          DEFICIT        TOTAL
                             ------------  --------  --------------  -------------  -------------  ------------
<S>                          <C>           <C>       <C>             <C>            <C>            <C>
BALANCE, JUNE 30, 2003. . .   124,296,257  $124,296  $    8,201,508  $     (5,247)  $(15,134,954)  $(6,814,397)
ISSUANCE OF COMMON
 STOCK FOR:
Cash (net of $85,871
 finders' fees paid). . . .    15,811,750    15,812       1,195,220             -              -     1,211,032
Issuance of shares for
 services . . . . . . . . .       800,000       800         110,200             -              -       111,000
Issuance of shares to
 settle debt. . . . . . . .     1,100,000     1,100          98,900             -              -       100,000
Issuance of common stock
 by subsidiary. . . . . . .             -         -             653             -              -           653
OTHER COMPREHENSIVE
 LOSS FOR THE SIX MONTHS
 PERIOD ENDED
 DECEMBER 31,  2003                                                        (1,206)             -        (1,206)
NET LOSS FOR THE SIX
 MONTHS PERIOD ENDED
 DECEMBER 31, 2003. . . . .             -         -               -             -       (762,364)     (762,364)
                             ------------  --------  --------------  -------------  -------------  ------------
BALANCE, DECEMBER 31, 2003    142,008,007  $142,008  $    9,606,481  $     (6,453)  $(15,897,318)  $(6,155,282)
                             ============  ========  ==============  =============  =============  ============
</TABLE>


                                        7
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS
(Unaudited)

<TABLE>
<CAPTION>

                                                                              SIX MONTHS ENDED
                                                                                DECEMBER 31,
                                                                             2003           2002
<S>                                                    <C>               <C>           <C>
CASH FLOWS FROM OPERATING
 ACTIVITIES:
Net loss from continuing operations                                      $(1,122,297)  $  (  637,206)
Adjustments to reconcile net loss to net
 cash provided (used) by operating
 activities
Depreciation                                                                   5,014          29,515
Consulting services                                                           61,000         104,550
Gain  on  settlement  of  debt                                               (35,139)              -
Changes in operating assets and liabilities:
Accounts receivable                                                           79,502      (  163,368)
Inventory                                                                   (  7,769)       (  2,732)
Prepaid expenses                                                              15,269          57,884
Accounts payable and accrued liabilities                                     (84,245)     (  108,457)
Corporation income taxes payable                                                   -           5,160
Costs and estimated profits in excess of billings on                               -      (  129,505)
 uncompleted contracts
Billings in excess of costs and estimated earnings on                      1,755,270      (  446,459)
 uncompleted contracts
                                                                           ---------      -----------
NET CASH FROM (USED BY) OPERATING                                            666,605    (  1,290,618)
 ACTIVITIES
                                                                           ---------      -----------

CASH FLOWS USED BY INVESTING
 ACTIVITIES:
Purchase of property and equipment                                          (  3,405)          3,679
Advances to subsidiary - discontinued operations                          (  198,969)     (  187,033)
Decrease in goodwill                                                               -          10,500
                                                                           ---------      -----------
NET CASH USED BY INVESTING                                               $(  202,374)  $  (  172,854)
 ACTIVITIES
                                                                           ---------      -----------
</TABLE>


                                        8
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS  (CONTINUED)
(Unaudited)

<TABLE>
<CAPTION>

                                                              SIX MONTHS ENDED
                                                                DECEMBER 31,
                                                             2003          2002
<S>                                    <C>               <C>           <C>
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in bank overdraft                               $         -   $    92,798
Net proceeds from common stock                             1,211,685       326,500
Payments on capital lease                                   (  2,615)     (  1,358)
Payments of equipment note                                         -      (  9,047)
Payments on notes payable                                  (  80,893)            -
Increase in due to related parties                                 -       617,982
                                                         ------------  ------------
NET CASH FROM FINANCING                                    1,128,177     1,026,875
 ACTIVITIES
                                                         ------------  ------------

EFFECT ON EXCHANGE RATE                                     (  1,206)        6,366
                                                         ------------  ------------
 CHANGES ON CASH AND CASH
 EQUIVALENTS

NET INCREASE (DECREASE) IN CASH                            1,591,202    (  430,231)
 AND CASH EQUIVALENTS FROM
 CONTINUING OPERATIONS

DECREASE IN CASH FROM                                              -     (  25,235)
 DISCONTINUED OPERATIONS
 - NOTE 3

CASH AND CASH EQUIVALENTS, AT                                  4,092       481,299
 BEGINNING OF PERIOD
                                                         ------------  ------------
CASH AND CASH EQUIVALENTS, AT                            $ 1,595,294   $    25,233
 END OF PERIOD
                                                         ============  ============

SUPPLEMENTAL DISCLOSURE OF
 CASH FLOW INFORMATION
CASH PAID DURING PERIOD FOR:
Interest                                                 $   450,237   $   207,365
                                                         ============  ============
Taxes                                                    $         -   $         -
                                                         ============  ============
NON-CASH INVESTING AND
 FINANCIAL ACTIVITIES

ISSUANCE OF COMMON STOCK FOR:
Prepaid expense                                          $    50,000   $         -
                                                         ============  ============
Services                                                 $    61,000   $   104,550
                                                         ============  ============
Settle convertible debentures                            $   100,000   $         -
                                                         ============  ============
</TABLE>


                                        9
<PAGE>

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

ORGANIZATION  AND  NATURE  OF  BUSINESS
---------------------------------------
SECURITY  BIOMETRICS, INC. AND EMEDRX, INC. (FORMERLY BIOMETRICS SECURITY, INC.)

Security Biometrics, Inc. (hereinafter referred to as "the Company") is a Nevada
corporation  incorporated  on  March  12,  1999.

On August 25, 2000, the Company acquired all of the issued and outstanding stock
of  Biometric  Security, Inc. (hereinafter referred to as "BSI") in exchange for
38,257,675  shares  of  the  Company's common stock. (37,500,000 of these shares
were  owned by a trust whose beneficiaries were the children of a officer of the
Company).  This  transaction has the effect of what is commonly referred to as a
"reverse acquisition" in that the Company is the legal acquirer; however, BSI is
the  accounting  acquirer.   In  connection  with  the  legal  form  of  this
transaction,  BSI  became  a  wholly-owned  subsidiary  of  the  Company.  For
accounting  purposes,  the  acquisition  is treated as a recapitalization of BSI
rather than a business combination. BSI was subsequently renamed eMedRx, Inc. on
December  2nd  2002.

The  Company  and  its subsidiaries intend to develop, market under license, and
distribute  dynamic  biometric  technologies.

BASIS  OF  PRESENTATION

The  unaudited  financial  statements of the Company as at December 31, 2003 and
2002,  and  for  the  six and three months ended December 31, 2003 and 2002 have
been prepared in accordance with accounting principles generally accepted in the
United  States  for  interim reporting.  Accordingly, they do not include all of
the  disclosures  required  by  accounting  principles generally accepted in the
United  States  for  complete financial statements and notes thereto included in
the  Company's  Form 10-KSB for the year ended June 30, 2003.  In the opinion of
management,  all  adjustments  (consisting only of normal recurring adjustments)
considered  necessary  for  a  fair  presentation  of  the  interim  financial
information have been included. The results of operations for any interim period
are not necessarily indicative of the results of operations for the entire year.

GOING  CONCERN

The  Company  experienced  significant  operating  losses  since  inception.  In
addition,  as  at  December  31, 2003, the Company has a working capital deficit
amounting  to  approximately $6.1 million. The consolidated financial statements
have  been  prepared  assuming  the  Company will continue to operate as a going
concern  which  contemplates  the  realization  of  assets and the settlement of
liabilities  in  the  normal course of business.  No adjustment has been made to
the  recorded  amount  of  assets  or  the  recorded amount or classification of
liabilities  which  would be required if the Company were unable to continue its
operations.   Management  has  negotiated  a financial reorganization plan which
the  Company  believes  should  address  some  or  all  of its present financial
condition.

PRINCIPLES  OF  CONSOLIDATION

The  consolidated  financial  statements  include  the  accounts  of  Security
Biometrics,  Inc.  and  the  following  subsidiaries:

eMedRX,  Inc.  (formerly  Biometrics  Security,  Inc.)
Lightec  Communications  Corp.
Datadesk  Technologies,  Inc.  (disposed  on  August  20,  2003)
eMedRx  Inc.
NetFace,  LLC  (Inactive)

All  material  inter-company  accounts  and  transactions  have been eliminated.


                                       10
<PAGE>

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

CASH  AND  CASH  EQUIVALENTS
----------------------------
For  purposes  of  the statement of cash flows, the Company considers all highly
liquid  debt  instruments purchased with an original maturity of three months or
less  to  be  cash  equivalents.

ACCOUNTING  ESTIMATES
---------------------
Management  uses  estimates  and assumptions in preparing consolidated financial
statements  in  accordance  with generally accepted accounting principles in the
United  States.  Those  estimates and assumptions affect the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities, and
the  reported  revenues  and  expenses.  Actual  results  could  vary  from  the
estimates  that  were  used.  Significant  estimates  used  in  these  financial
statements include fair values and impairment analysis of the Company's Property
and  Equipment.

REVENUE  AND  COST  RECOGNITION
-------------------------------
LIGHTEC
-------
Lightec  recognizes  revenues  from  fixed-price  and  modified  fixed-price
construction  contracts  on the percentage-of-completion method, measured by the
percentage  of  cost incurred to date to estimated total cost for each contract.
This  method  is  used  because  management  considers total cost to be the best
available  measure  of  progress  on  the  contracts.  Because  of  inherent
uncertainties  in  estimating costs, it is at least reasonably possible that the
estimates  used  will  change  within  the  near  term.

Revenue from time-and-materials contracts is recognized currently as the work is
performed.

Contract  costs  include  all direct material and labor costs and those indirect
costs  related to contract performance, such as indirect labor, supplies, tools,
repairs,  and  depreciation.  Selling,  general  and  administrative  costs  are
charged  to expense as incurred.  Provisions for estimated losses on uncompleted
contracts  are  made in the period in which such losses are determined.  Changes
in  job  performance,  job conditions, and estimated profitability may result in
revisions  to  costs and income, which are recognized in the period in which the
revisions are determined.  Changes in estimated job profitability resulting from
job  performance,  job  conditions,  contract  penalty  provision, claims change
orders and settlements, are accounted for as changes in estimates in the current
period.

The  asset,  "Costs  and estimated earnings in excess of billings on uncompleted
contracts",  represents  revenues  recognized  in excess of amounts billed.  The
liability,  "Billings  in  excess of costs and estimated earnings on uncompleted
contracts",  represents  billings  in  excess  of  revenues  recognized.

Revenue  from  claims  is recognized when realization is probable and the amount
can  be reliably estimated.  When realization is probable, but the amount cannot
be  reliably  estimated,  revenue is recognized to the extent of costs incurred.

Accounts  Receivable
--------------------
Accounts receivable are reported at the customers' outstanding balances less any
allowance  for  doubtful  accounts, marketing credits and allowance for possible
sales  returns.


                                       11
<PAGE>

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

ALLOWANCE  FOR  DOUBTFUL  ACCOUNTS, MARKETING CREDITS AND ALLOWANCE FOR POSSIBLE
--------------------------------------------------------------------------------
SALES  RETURNS
--------------
The  allowance  for doubtful accounts is charged to income in amounts sufficient
to  maintain  the  allowance at a level management believes is adequate to cover
any  possible  losses,  credits  or  returns.

INVENTORY
---------
The  Company's  inventory  is  stated  at  the  lower of cost (determined on the
first-in,  first-out  method)  or  market.

PROPERTY  AND  EQUIPMENT
------------------------
Property  and Equipment are stated at cost.  Major renewals and improvements are
charged to the asset accounts while replacements, maintenance and repairs, which
do  not  improve or extend the lives of the respective assets, are expensed.  At
the  time property and equipment are retired or otherwise disposed of, the asset
and  related  accumulated  depreciation  accounts are relieved of the applicable
amounts.  Gains  or  losses from retirements or sales are credited or charged to
income.

The  Company  depreciates  its  property  and  equipment for financial reporting
purposes using the straight-line method based upon the following useful lives of
the  assets:

Furniture  and  fixtures         7-10  Years
Machinery  and  equipment           5  Years
Computer  equipment                 5  Years

ACCOUNTING  FOR  CONVERTIBLE  DEBT  SECURITIES
----------------------------------------------
The  Company  has  issued  convertible  debt  securities  with  a non-detachable
conversion  feature  that were "in the money" at the date of issue.  The Company
accounts for such securities in accordance with Emerging Issues Task Force Topic
98-5.  The  Company  has  recorded  the  fair value of the beneficial conversion
feature  as  an  interest  expense  and  increase in Additional Paid-In Capital.

The  beneficial  interest  is computed by subtracting the stock conversion price
from  the  market  price  of  the  stock times the number of shares and warrants
eligible  for  conversion.

INCOME  TAXES
-------------
Provisions  for  income  taxes  are based on taxes payable or refundable for the
current  year  and deferred taxes on temporary differences between the amount of
taxable  income  and pretax financial income and between the tax basis of assets
and  liabilities  and  their  reported  amounts  in  the  financial  statements.
Deferred  tax assets and liabilities are included in the financial statements at
currently  enacted  income  tax  rates  applicable  to  the  period in which the
deferred  tax  assets  and liabilities are expected to be realized or settled as
prescribed in Statement of Financial Accounting Standards ("SFAS") SFAS No. 109,
Accounting  for  Income  Taxes.  As  changes  in  tax laws or rates are enacted,
deferred  tax  assets  and  liabilities  are  adjusted through the provision for
income  taxes.

NET  (LOSS)  PER  SHARE
-----------------------
The  Company  adopted SFAS No. 128 that requires the reporting of both basic and
diluted  (loss)  per  share.  Basic (loss) per share is computed by dividing net
(loss) available to common stockholders by the weighted average number of common
shares  outstanding  for  the  period.  Diluted  (loss)  per  share reflects the
potential  dilution  that  could occur if securities or other contracts to issue
common  stock  were exercised or converted into common stock. In accordance with
SFAS  No.  128,  any  anti-dilutive effect on net (loss) per share are excluded.


                                       12
<PAGE>

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

LONG-LIVED  ASSETS
------------------
SFAS  No. 144, "Accounting for the Impairment or Disposal of Long-lived Assets,"
requires  that  long-lived  assets be reviewed for impairment whenever events or
changes  in  circumstances  indicate  that  the  carrying amount of the asset in
question  may not be recoverable.  For the six month period ended December 31,
2003,  this  standard did not have a material effect on the Company's results of
operations,  cash  flows  or  financial  position.

DISCLOSURE  ABOUT  FAIR  VALUE  OF  FINANCIAL  INSTRUMENTS
----------------------------------------------------------
The  Company  estimates  that  the fair value of all financial instruments as of
December  31,  2003, as defined in SFAS No. 107, does not differ materially from
the  aggregate  carrying  values  of  its  financial instruments recorded in the
accompanying  balance  sheet.  The  estimated  fair  value  amounts  have  been
determined  by  the  Company  using available market information and appropriate
valuation  methodologies.  Considerable  judgment  is  required  in interpreting
market  data  to  develop  the  estimates  of  fair  value, and accordingly, the
estimates  are  not necessarily indicative of the amounts that the Company could
realize  in  a  current  market  exchange.

STOCK-BASED  COMPENSATION
-------------------------
The  Company  has  elected to account for stock-based compensation following APB
No.  25  "Account  for  Stock  Issued  to  Employees",  and  provides disclosure
requirements  under  SFAS  No. 123 "Accounting for Stock-based Compensation", as
amended  by  FASB  No. 148, Accounting for Stock-based Compensation - Transition
and  Disclosure,  an  amendment  of  SFAS  No.  123.

STOCK  ISSUED  BY  SUBSIDIARY
-----------------------------
The issuance of stock by a subsidiary to third parties reduces the proportionate
ownership  interest  in  the  investee.  The  subsidiary's  plan  is to continue
raising  funds through private placements and as a result, the additional equity
raised  has  been  included  in  additional  paid-in  capital.

COMPREHENSIVE  INCOME
---------------------
The  Company  has  adopted  SFAS  No.  130,  "Reporting  Comprehensive  Income".
Comprehensive  income  is comprised of foreign currency translation adjustments.

FOREIGN  CURRENCY  TRANSLATION
------------------------------
The  financial  statements  of  the Company are measured using the United States
dollar as the functional and reporting currency.  Assets, liabilities and equity
accounts  of  the  Company are translated from foreign currency to United States
currency  at  exchange  rates  as  of  the  balance  sheet  date  or  historical
acquisition date, depending on the nature of the account.  Revenues and expenses
are  translated  at  average  rates  of exchange in effect during the year.  The
resulting  cumulative  translation  adjustments have been recorded as a separate
component  of  stockholders'  equity.

SHIPPING  AND  HANDLING  COSTS
------------------------------
The  Company's policy is to classify shipping and handling costs as part of cost
of  goods  sold  in  the  statement  of  operations.


                                       13
<PAGE>

NOTE  2     DISPOSITION  OF  DISCONTINUED  OPERATIONS

During  the six month period ended December 31, 2003, the Company entered into a
Stock  and  Note Transfer Agreement (the "Transfer Agreement") with Pan Pacifica
Ltd.  ("Pan  Pacifica"), effective as of August 20, 2003, to transfer all of the
outstanding  shares of Datadesk, a wholly-owned subsidiary of the Company, and a
promissory  note payable to the Company made by Datadesk in the principal amount
of  $1,000,000,  together  with  the  related security interest in the assets of
Datadesk  to  Pan  Pacifica.   The  Transfer  Agreement  was  entered  into
simultaneously  with  a  settlement agreement between the Company and its former
officer.  In  connection  with the settlement, the Company transferred available
funds  in  the  amount  of  $151,020  to  Pan  Pacifica.

The  Company  realized  a  net  gain  on  the disposal of Datadesk subsidiary of
$382,073  which was recognized at the date of disposition.  The realized gain is
net  of  approximately  $47,949  transaction  costs.

Loss  from  discontinued  operations  is  as  follows:

<TABLE>
<CAPTION>
                                             Six months ended               Three months ended
                                                December 31,                  December 31,
                                          2003                 2002          2003      2002
                                   ------------------  --------------------  -----  ----------
<S>                                <C>                 <C>                   <C>    <C>
Revenue . . . . . . . . . . . . .  $           6,431   $           209,471   $   -  $  61,570
Direct expenses . . . . . . . . .                  -                84,920       -     56,895
                                   ------------------  --------------------  -----  ----------
                                               6,431               124,551       -      4,675
Gross profit

Administrative and General. . . .            (28,571)             (359,024)      -   (160,046)
Interest expenses . . . . . . . .                  -                  (457)      -       (235)
                                   ------------------  --------------------
Net operating loss. . . . . . . .            (22,140)             (234,930)      -   (155,606)
Other item
Gain on disposition of subsidiary            382,073                     -       -          -
                                   ------------------  --------------------
Income (loss) from discontinued
 operations for the period. . . .  $         359,933   $          (234,930)  $   -  $(155,606)
                                   ==================  ====================  =====  ==========
</TABLE>

NOTE  3     STATEMENT  OF  CASH  FLOWS

Cash  flows  from  discontinued  operations  are  as  follows:

<TABLE>
<CAPTION>
                                                                    2003        2002
                                                                 ----------  ----------
<S>                                                              <C>         <C>
Operating Activities
Net income (loss) for the period. . . . . . . . . . . . . . . .  $ 359,933   $(234,930)
Items not involving cash:
Amortization of capital assets. . . . . . . . . . . . . . . . .          -       5,648
Gain on disposition of subsidiary . . . . . . . . . . . . . . .   (382,073)          -
Changes in non-cash working capital balances consist of:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . .     (2,910)     49,504
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . .      2,375       9,024
Accounts payable and accrued liabilities. . . . . . . . . . . .   (182,198)    (48,711)
                                                                 ----------  ----------
                                                                  (204,873)   (219,465)
                                                                 ----------  ----------
Investing Activity
Purchase of capital assets. . . . . . . . . . . . . . . . . . .          -      (4,004)
                                                                 ----------  ----------

Financing Activities
Loans receivable from related party . . . . . . . . . . . . . .          -      11,200
Bank indebtedness . . . . . . . . . . . . . . . . . . . . . . .      5,904           -
Due to related party. . . . . . . . . . . . . . . . . . . . . .    198,969     187,033
                                                                 ----------  ----------
                                                                   204,873     198,234
                                                                 ----------  ----------
Decrease in cash from discontinued operations during the period  $       -   $ (25,235)
                                                                 ==========  ==========
</TABLE>


                                       14
<PAGE>

NOTE  4     ACCOUNTS  RECEIVABLE

A  summary  of  accounts  and  other  receivable  is  as  follows:
<TABLE>
<CAPTION>
<S>                                                                               <C>
Account receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 15,213
Less: allowance for doubtful accounts, sales returns, and advertising incentives   (10,995)
                                                                                  ---------
                                                                                     4,208
Tax credits recoverable. . . . . . . . . . . . . . . . . . . . . . . . . . . . .    10,924
                                                                                  ---------

Total accounts receivable. . . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 15,132
                                                                                  =========
</TABLE>

NOTE  5     PROPERTY  AND  EQUIPMENT

Property  and  equipment  and  accumulated  depreciation  consists  of:
<TABLE>
<CAPTION>
<S>                                              <C>
Furniture and fixtures                            $64,198
Computer equipment                                 17,152
                                                  -------
                                                   81,350
Less accumulated depreciation                      17,941
                                                  -------
Total property and equipment.                     $63,409
                                                  =======
</TABLE>

NOTE  6     CAPITAL  LEASE  PAYABLE

The  Company  acquired an office copier on a capital lease with National Leasing
Group,  Inc.  The  lease  requires monthly payments of approximately $400 for 48
months  including  interest  at  11%  per annum.  Future minimum payments are as
follows:

<TABLE>
<CAPTION>
<S>                                     <C>
June 30, 2004                                     $ 2,615
June 30, 2005                                         872
                                                  --------

Total minimum lease payment                         3,487
Less amount representing interest                  (1,340)
                                                  --------
Present value of minimum lease payment            $ 2,147
                                                  ========
</TABLE>


                                       15
<PAGE>

NOTE  7     NOTES  AND  CONVERTIBLE  DEBENTURE  PAYABLE

<TABLE>
<CAPTION>
                                                                                          DECEMBER 31,
MARYANNE RICHARD                                                                             2003
                                                                                       -----------------
<S>                                                                                    <C>
On  June  13, 2002, the Company issued a note payable to Maryanne Richard in the
amount  of  $1,000,000 as part of the consideration for the purchase of Lightec.
Included  in  accrued  liabilities  at  December  31, 2003 is $36,193 of accrued
interest.  The note is secured by deposit accounts, investment property, letters
of  credit rights and letters of credit, rights to payments evidenced by chattel
paper,  rights  to payments for money or funds advanced or sold and all proceeds
of any and all of the above.  The security is senior in priority to the security
granted  for  the  $1,000,000 note payable to Synergex Group and subordinated to
that of Edinburgh LLC. Consideration of 8,000,000 stock purchase warrants, which
gives  the  rights to the holder to acquire one share of common stock at a price
of  $0.125 for a period of two years, was given to extend the repayment terms by
three  months  to  commence  on  December  31,  2002.

Pursuant  to  an agreement dated October 29, 2003, the Company has agreed to set
the principal of the note at $1,105,000 ("new principal").  Interest will accrue
on  the  new principal at the rate of 9% per annum commencing on the date of the
first  receipt  of  funds from the Bridgeport School contract.  Payments against
the  new  principal and accrued interest will commence once the $55,413 included
in  accounts  payable - related entities, has been repaid.  This $55,413 is owed
to  Mike  Richard  (a  former  director  of  Lightec)  pursuant to an employment
contract.  9%  of  the  receipts  from  the  Bridgeport  School contract will be
applied  against  these  debts.                                                        $       1,105,000

SYNERGEX  GROUP  PARTNERSHIP
On  June  11,  2002, Synergex Group Partnership loaned the Company $1,000,000 to
facilitate  the  acquisition of Lightec. The note bears interest at 9%. Included
in  accrued  liabilities  at  December 31, 2003 is $138,863 of accrued interest.
The note is secured by Lightec deposit accounts, investment property, letters of
credit  rights  and  letters  of credit, rights to payments evidenced by chattel
paper,  rights  to payments for money or funds advanced or sold and all proceeds
of  any  and  all  of  the  above.  The security is subordinated to the security
granted  for  the $1,000,000 note payable to Mary Anne Richard. Consideration of
8,000,000  stock  purchase  warrants,  which  gives  the rights to the holder to
acquire  one  share  of  common  stock  at a price of $0.125 for a period of two
years,  was  given  to extend the repayment terms by three months to commence on
December  31,  2002.  Gerard  Munera,  who  is  a director of the Company has an
ownership  stake  and  is  the  managing  director  of  the  Synergex  Group.

Pursuant  to  an  agreement dated September 12, 2003, the Company is required to
pay  the  following:

i)  pay  the  principal  plus  all interest accrued in the outstanding principal
balance  at  the  rate  of  9%  per  annum from the date of receipt of the first
payment  related  to  the  Bridgeport  School  contract  until  paid  in  full;

ii)  pay  no  less  than 7.4% of all money received on account of the Bridgeport
School  contract  until  paid  in  full  (paid to December 31, 2003:  $185,893).
                                                                                                 814,107
                                                                                       $       1,919,107
                                                                                       -----------------
</TABLE>


                                       16
<PAGE>

NOTE  7     NOTES  AND  CONVERTIBLE  DEBENTURE  PAYABLE  (CONTINUED)

<TABLE>
<CAPTION>
                                                                                          DECEMBER 31,
EDINBURGH INVESTMENTS LLC                                                                    2003
                                                                                       -----------------
<S>                                                                                    <C>
On  June  30,  2002,  the  Company  issued  a convertible debenture to Edinburgh
Investments  LLC  ("Edinburgh").  The debenture is secured in the first priority
against  the revenues and assets of the Lightec business and matured on June 30,
2003  and  accrued  interest  at  10%  payable  quarterly.

On  August 29, 2003, Edinburgh obtained a court order for settlement against the
Company  requiring  the  Company  to  pay  the  following:

i)  pay  Edinburgh  $50,000  on  each of December 31, 2003, October 31, 2003 and
November  28,  2003  ($150,000  paid);

ii)  pay Edinburgh the principal plus all  interest  accrued  on the outstanding
principal  balance at the rate of 18% per annum from June 28, 2002 until paid in
full.  All outstanding principal and accrued interest shall be paid to Edinburgh
no  later  than  December  31,  2004.  At December 31, 2003, accrued interest is
$80,517;

iii)  pay Edinburgh the accrued interest for December 31, 2003 onward on January
5,  2004,  April  5,  2004,  July  15,  2004  and  October  5,  2004;

iv)  pay Edinburgh 15% of all funds received from the Bridgeport School contract
until  the  principal  and  interest  is  fully paid (paid to December 31, 2003:
$376,811);  deliver  to  Edinburgh  a  five  year warrant to purchase 13,440,000
common  stock  at  an  exercise  price  of  $0.15  per  share
                                                                                       $   1,680,000
                                                                                       =============
</TABLE>

The  Company  was  notified by Edinburgh that it was not in technical compliance
with  the  terms  of  the  settlement but these requirements are currently being
remedied.

<TABLE>
<CAPTION>
Summary  of  Creditor  Repayment
--------------------------------
     CREDITOR       SECURITY PRIORITY  PROPORTION OF GROSS LIGHTEC
------------------  -----------------  ----------------------------
                                             REVENUE PAYABLE
                                       ----------------------------
<S>                 <C>                <C>
Edinburgh LLC. . .                1st                           15%
Maryanne Richard .                2nd                            9%
Synergex Group LLC                3rd                          7.4%
Total                                                         31.4%
                                                             ------
</TABLE>


                                       17
<PAGE>

NOTE  8     STOCK  WARRANTS  AND  OPTIONS

1.     The  company  has  the  following  warrants  outstanding:
<TABLE>
<CAPTION>

  NUMBER      PRICE         EXPIRATION
OF SHARES   PER SHARE          DATE
----------  ----------  ------------------
<C>         <C>         <S>
 1,810,000  $     0.15  February 17, 2004
    20,000  $     0.15  February 27, 2004
7,083,333*  $     0.15  June 13, 2005
12,019,880  $     0.15  September 18, 2005
 2,757,500  $     0.15  November 19, 2005
 2,790,500  $     0.15  December 22, 2005
</TABLE>

*     The Company has the right to force the conversion of these warrants if the
stock  price  of the Company's common stock exceeds $1.20 per share for a ninety
day  period.

2.     The  Company has agreed to issue additional warrants in consideration for
extension  agreements on notes payable for 16,000,000 shares at $0.125 per share
for  a  period  of  two  years  (see  Note  7)

3.     During the period, the Company settled $100,000 of convertible debentures
by issuing 1,100,000 shares and agreed to issue 1,100,000 warrants entitling the
holder  thereof  the right to purchase one common share for each warrant held at
$0.15  per  share  for  a  period  of  two  years.

4.     Pursuant  to  a  court order, the Company is required to issue 13,440,000
warrants  as  part of a settlement of it's convertible debentures.  Each warrant
entitles  the  holder thereof the right to acquire one common share at $0.15 per
share  for  a  period  of  five  years  (see  Note  7).


                                       18
<PAGE>

NOTE  8     STOCK  WARRANTS  AND  OPTIONS  (CONTINUED)

5.     Stock-based  Compensation  Plan

On  April  29, 2002, the Company adopted the 2002 employee stock option plan for
the  purpose  of  providing  an  incentive  based  form  of  compensation to the
officers,  directors, key employees and service providers of the Company.  These
options  were  granted  with  an exercise price equal to the market price of the
Company's  stock  on  the  date  of  the  grant.

<TABLE>
<CAPTION>
                                                         December 31, 2003
                                                                        Weighted
                                                      Optioned           Average
                                                       Shares        Exercise Price
                                                  -----------------  ---------------
<S>                                               <C>                <C>
Outstanding, beginning of the year . . . . . . .          4,234,091  $          0.11
Granted. . . . . . . . . . . . . . . . . . . . .          4,050,000             0.12
                                                  -----------------  ---------------
Outstanding and exercisable at end of the period          8,284,091  $          0.11
                                                  =================  ===============

</TABLE>

At  December  31,  2003 the following consultant or employee and director common
share  purchase  options  were outstanding and exercisable entitling the holders
thereof  the  right  to purchase one common share for each share purchase option
held:

<TABLE>
<CAPTION>
           Exercise   Expiry
 Number      Price    Date
---------  ---------  ----------------
<C>        <C>        <S>
2,859,091  $    0.11  April 28, 2004
1,000,000  $    0.11  April 30, 2004
  100,000  $    0.20  June 20, 2004
   50,000  $    0.17  October 7, 2004
  100,000  $    0.14  October 14, 2004
4,000,000  $    0.11  July 6, 2005
   50,000  $    0.11  August 31, 2005
  125,000  $    0.11  June 27, 2012
---------
8,284,091
=========
</TABLE>

The  Company accounts for its stock-based compensation using the intrinsic value
method in accordance with Accounting Principles Board Opinion No. 25 "Accounting
for  Stock  Issued  to  Employees"  and  its  related  interpretations.


                                       19
<PAGE>

NOTE  8     STOCK  WARRANTS  AND  OPTIONS  (CONTINUED)

5.     Stock-based  Compensation  Plan  -  (continued)

Under  SFAS  No. 123, if the Company elects to follow APBO No. 25, in respect to
the  employees stock options, it is required to present pro-forma information as
to  the  effect on income and earnings per share as if the Company had accounted
for  its  employee  stock options under the fair value method of that statement.
Had compensation cost been determined based on the fair value at the grant dates
for those options issued to officers, directors and employees, the Company's net
loss  and  loss  per  share  would  have  been adjusted to the pro-forma amounts
indicated  below:

<TABLE>
<CAPTION>
                                           December 31,
                                        2003          2002
                                   --------------  ----------
<S>                                <C>             <C>
Net loss. . . . . . . . . . . . .  $    (607,933)  $(872,136)
Pro-forma adjustment for SFAS 123       (283,500)          -
                                   --------------  ----------
Pro-forma net loss. . . . . . . .  $    (891,433)  $(872,136)
                                   ==============  ==========
Pro-forma net loss per share. . .  $       (0.01)  $   (0.01)
                                   ==============  ==========
</TABLE>

The fair value of these options was estimated at the date of the grant using the
following  weighted  average  assumption:

<TABLE>
<CAPTION>
                                                                  2003
                                                                --------
<S>                                                             <C>
Volatility factor of expected market price of company's shares      199%
Dividend yield . . . . . . . . . . . . . . . . . . . . . . . .        0%
Weighted average expected life of stock options. . . . . . . .  2 years
Risk-free interest rate. . . . . . . . . . . . . . . . . . . .        5%
</TABLE>

The Black-Scholes option valuation model was developed for use in estimating the
fair  value  of  traded options which have no vesting restrictions and are fully
transferable.  In  addition, option valuation models require the input of highly
subjective  assumptions,  including  expected  share  price  volatility.  The
Company's  employee  stock  options have characteristics significantly different
from  those  of  traded options, and changes in the subjective input assumptions
can  materially  affect  fair  value  estimates.

NOTE  9     BUSINESS  SEGMENTS

SFAS  No.  131,  "Disclosure  about  Segments  of  an  Enterprise  and  Related
Information",  requires  companies  to  provide  certain information about their
operating  segments.  The  Company  has  three  reportable  segments:  Security
Biometrics,  Lightec,  and  eMedRx.

Summarized  financial  information, concerning the Company's reportable segments
for  six  months  ended  December  31,  2003, is shown on the following table:

<TABLE>
<CAPTION>
                                    SECURITY
                                   BIOMETRICS    LIGHTEC     EMEDRX       TOTAL
<S>                               <C>           <C>         <C>        <C>
Net sales to external companies.  $    12,067   $1,707,224  $      -   $1,719,291
Operating earnings (loss). . . .   (1,659,571)     585,739   (48,465)  (1,122,297)
Total assets . . . . . . . . . .      199,879    1,525,997     9,523    1,735,399
Depreciation and amortization. .        4,554          460         -        5,014
Capital expenditures . . . . . .        3,405            -         -        3,405
</TABLE>

NOTE  10     COMMITMENT

On  December 2, 2003, the Company signed a letter of intent to acquire WonderNet
Ltd.  of  Israel  for  cash  and  shares  of  the  Company's  stock.

Subject  to  final  due  diligence  and  a  formal  agreement  being signed, the
transaction  is  scheduled to close on or before February 29, 2004.  There is no
assurance  that the final agreement will be signed and that the transaction will
close.


                                       20
<PAGE>

PART  I

ITEM  2     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION

When  used  in  this Form 10-QSB, the words "anticipated", "estimate", "expect",
and  similar  expressions  are  intended to identify forward-looking statements.
Such  statements  are  subject  to  certain risks, uncertainties and assumptions
including  the  possibility  that  we  will  fail  to generate planned revenues.
Should  one  or  more  of  these  risks  or uncertainties materialize, or should
underlying  assumptions prove incorrect, actual results may vary materially from
those  anticipated,  estimated  or  projected.

We  believe  the  risks  include,  but  are  not  limited to, the failure of the
biometric  technology market to grow according to our expectations due to slower
adoption  of  biometric  technology than our forecasts, commercial risk from the
potential adoption of other biometric technologies as a substitute for biometric
signature authentication and commercial risk that a superior biometric signature
authentication  technology  could come to market before the Company's technology
has  realized  its  commercial  potential.

The  following  discussion  and  analysis of financial conditions and results of
operation  should  be  read  in  conjunction  with  our  consolidated  financial
statements  and  notes  thereto  included  elsewhere  in  this  Form  10-QSB.

Critical  Accounting  Policies
==============================

Our discussion and analysis of our financial condition and results of operations
are  based  upon  our  consolidated  statements,  which  have  been  prepared in
accordance  with  accounting principles generally accepted in the United States.
The  preparation of these financial statements requires us to make estimates and
judgments  that affect the reported amounts of assets, liabilities, revenues and
expenses.  In  consultation  with our Board of Directors and Audit Committee, we
have identified one accounting policy that we believe is key to an understanding
of  our  financial  statements.  This  is  an  important  accounting policy that
requires  management's  most  difficult,  subjective  judgment.

The  critical  accounting  policy relates to revenue recognition.  The choice of
revenue  recognition method is subjective.  License revenues are recognized when
earned,  in  accordance  with  contractual  provisions.  Royalty  revenues  are
recognized upon shipment of products incorporating the related technology by the
original  equipment  manufacturers  (OEMs)  and  foundries.  For  Lightec,  we
recognize  revenue  from  fixed  price  and  modified  fixed  price construction
contracts  on the percentage-of-completion method, measured by the percentage of
cost  for each contract.  This method is used because management considers total
cost  to  be  the  best  available  measure  of  progress  on  the  contracts.

History
=======

Security  Biometrics, Inc. was incorporated as Great Bear Resources, Inc. in the
State  of  Nevada  on  March  12,  1999  and  we  changed our name to Great Bear
Investments,  Inc.  on May 25, 1999.  On August 11, 2000, we changed our name to
Security  Biometrics,  Inc.  We were a development state company whose objective


                                       21
<PAGE>

was  to  develop  market  under  license  and  distribute  dynamic  biometric
technologies  specific  to  the  security  applications of banking and financial
transactions,  including  dynamic  gesture  recognition  technology,  dynamic
signature  verification  and  voice  recognition.

On  August  22,  2000,  we entered into an option agreement with DSI Datotech of
Vancouver,  Canada. The exercise price of the option was $8,000,000, of which we
paid  $320,000.  On June 29, 2001, we acquired all of the outstanding membership
interests  of NetFace, LLC, a Connecticut limited liability company, in exchange
for  20,000,000 share of our common stock. NetFace holds an option to acquire an
exclusive  worldwide,  perpetual,  royalty-free license to exploit DSI's gesture
recognition  technology  for  video  games and Internet/television. The exercise
price  of  the option is $5,000,000 plus a 20% Class B Membership of NetFace. We
have decided not to exercise our options with DSI Datotech at this time as we do
not  believe  that the prototypes delivered to us are market ready at this time.
Consequently,  the  Company  expensed  $320,000  in  2001 and the balance of the
investment  of  $200,000  in  2002.

On  April  20,  2002,  the  Company  entered  into  an  exclusive agreement with
WonderNet  Ltd.  of  Israel.  Under  this  agreement,  we  became  the exclusive
distributor for North America, the Caribbean and Mexico of WonderNet's Penflow()
patented  and  proprietary  Biometric  Signature Authentication ("BSA") software
engine,  which  consists  of  a  database of user profiles and enable remote and
local access to the database using the internet, smart cards, or LAN connections
to  verify  signatures by comparison to said database.  To acquire these rights,
we issued WonderNet 2,500,000 shares of common stock and agreed to pay WonderNet
a  5%  royalty  on  products  sold.

The  agreement  with  WonderNet allows us to commence sub-licensing, marketing a
proven  biometric  security  product.

A  revised  agreement  with  Wondernet was entered into in September 2003.  This
agreement  includes a minimum payment of $120,000 per quarter against royalties.
Because  royalty  payments  did  not  reach  $120,000  during  the period ending
December  31,  2003,  we  paid  this  from  cash.

Wondernet
=========

On  December  1 2003, a letter of intent was signed between Security Biometrics
and Wondernet for Security Biometrics to buy the stock of Wondernet for cash and
Security  Biometrics  stock.

We believe that the purchase of Wondernet would confer a number of advantages on
Security  Biometrics  including  strategic  control of the underlying technology
going  forward  and  enhanced  future  margins  through the removal of royalties
payable  to  Wondernet.

The  due  diligence  called  for  in  the  letter of intent are not complete and
negotiations  are  on-going.

Management  Team
================

There  were  substantial  changes  to  the management team in the third calendar
quarter  of  2003.  Michel  Berty  was  appointed  Chief Executive Officer (CEO)
shortly  before  the  financial year end in June 2003 following the death of the
former  CEO  Mr  Kenneth Barr.  Mr Berty subsequently appointed William Moore as
Chief  Financial  Officer CFO on September 1, 2003, Jeffrey Maynard as president
and CEO of eMedRX on September 8, 2003 and Herve Bertacchi as vice president and
manager of the Lightec Communications business (August 18, 2003).  The executive
management  was  also  relocated  from  Vancouver,  Canada to New York City, USA
reflecting  the  increased  focus  of  the company's business to the larger U.S.
market.

Revised  Sales  Strategy
========================

The  executive  management  team  has  refocused  on sales on direct channels to
clients  rather than using alternate channels like value added resellers (VARS).
This  resulted  in  the  hiring  of additional sales staff in the third calendar
quarter.  In  the  first quarter of calendar year 2004 an agreement in principle
to purchase Datagility (see below) was made contingent on the sales resources of
Datagility  being redeployed to serve both Datagility and Penflow clients in the
financial  services  sector.

The  strategy of direct sales reflects a desire to maintain superior margins and
'customer  ownership.'  However,  Security  Biometrics  will  continue  to  use
in-direct  channels  where appropriate as a supplement to direct channels and to
ensure  as  much market breadth as possible given the resources available to the
business.


                                       22
<PAGE>

We  believe  that the sales cycle for the Penflow product is relatively long due
to  the  potential impact on client's business processes where it is implemented
on  a  large  scale.  We  believe  that  the  length of the sales cycle for this
product  means  that  increased investment in sales and marketing is unlikely to
have  a  significant impact on revenue performance until at least the later half
of  our  financial  year.

eMedRX
======

In  the  period ending December 31, 2003 the eMedRX business was managed through
two  subsidiaries  of Security Biometrics Inc, eMedRX, Inc. (formerly Biometrics
Security,  Inc.)  and  eMedRX  Inc.,  a Canadian company, in order to facilitate
business  in  each  country  and to provide opportunities for other investors to
participate  in  ownership  of  the  business.

We  believe  that  the  progress  made  in identifying pilot partners during the
quarter was significant.

Discussions  were  initiated  by  eMedRX  Inc.  to sell the U.S. rights to sell,
market  and  implement  the  eMedRX  product and Penflow application in the U.S.
healthcare  delivery  market  to  eMedRX  Inc. (USA) a company only related by a
common  director.  eMedRX  Inc.  (USA)  is a company formed specifically for the
purpose  of  selling,  marketing  and  implementing and servicing the eMedRX and
Penflow  products  by  a  management  group  with strong links to the healthcare
delivery  market.  In  return  for the rights to the product Security Biometrics
would receive consideration of 49% of the stock of eMedRX Inc. (USA) and license
fees  for  product  sales  and  transaction  revenues.  We  believe  that  this
arrangement  provides  excellent  access  to the vertical market for the product
while effectively preserving Security Biometric's sales and marketing resources.
David  Dalton,  one  of our directors, is director of and will have an ownership
interest  in  both  eMedRX  Inc.  (USA)  and  eMedRX,  Inc.

Lightec
=======

The  Lightec  Communications  business  continued to be active during the fourth
calendar  quarter.  Lightec  recognized $1,707,224 revenue for the period ending
December  31,  2003.  $158,524  was  recognized  during the prior quarter ending
September  30,  2003.  We  do  not  expect  this  rate of growth to be sustained
because  it  reflected  an  increased  level of contract activity with education
sector  customers.  It  should  be  noted  that  the revenue to be recognized in
future  quarters  is  effected  by  the  seasonality  of  contract activity.  We
anticipate th at the third calendar quarter will see reduced activity coinciding
with  school  vacations.

Funds for the Bridgeport Board of Education projects continued to be released by
the  government  agencies  involved  as  anticipated.  We believe that there are
grounds  to expect that the anticipated contracts revenues of $6,900,000 will be
achieved  in  the  contract  year  (ending  August  30,  2004).

Penflow
=======

Additional  resources  have  been  applied to sales and marketing of the Penflow
products.  We believe that the sales cycle for the Penflow product is relatively
long  due  to  the  potential  impact on client's business processes where it is
implemented  on a large scale. We believe that the length of the sales cycle for
this  product means that increased investment in sales and marketing is unlikely
to  have a significant impact on revenue performance until the later half of our
financial  year.

UK Subsidiary
============

Security  Biometrics  has  entered  into  a  contract  with  a  UK  marketing
representative  to  assist  in  the selling and marketing of Security Biometrics
products  in  the UK and Europe.  A company, Security Biometrics Ltd. was formed
subsequent  to  December  31,  2003 in anticipation of future business activity.

Datadesk

The divestiture of Datadesk was completed in August 2003 as previously described
in  our  annual  filing  on  form  10-KSB for the year ended June 30, 2003.  The
Datadesk  operation produced some of the core elements of the eMedRX application
but  going  forward it was decided to focus the resources of Security Biometrics
on  its Penflow technology and further development of the eMedRX application and
commercial  opportunities  in  the  healthcare  sector.


                                       23
<PAGE>

In  order  to  execute  the  divestiture  it  was  mutually  agreed  by Security
Biometrics  and  Robert  Solomon  (president  of  Datadesk  and  CTO of Security
Biometrics) to cancel Mr Solomon's employment agreement with Security Biometrics
and  transfer  ownership  of  Datadesk  to  Panpacifica  for  a consideration of
$1,000,000 .  The effective date of this agreement and transfer of the ownership
was  August  20,  2003.

The  company  realized  a  net  gain  in  the  disposal  of  the of the Datadesk
subsidiary  of  $382,073  which  was  recognized at the time of disposition. The
realized  gain  was  net  of  $47,949  transaction  costs.

The  transaction  constitutes a related party transaction because Robert Solomon
was  Chief  Technology Officer of Security Biometrics and President and director
of  Datadesk.

Purchase  of  Datagility
========================

Security  Biometrics  agreed in principle to purchase Datagility on December 22,
2003.  Datagility  is  a  software company specializing in anti-money laundering
solutions  and  application service provider (ASP) services.  In January 2003, a
letter  of  intent  was  signed by both parties and a resolution authorizing the
transaction  was passed by the board of Security Biometrics on February 5, 2004.
However,  at  the  current  time,  no  contract  has  been  signed.

The purchase would result in the acquisition of 100% of Datagility's outstanding
stock  in  return  for  a  consideration  of cash and Security Biometrics stock.

The  company's  principle  asset  is the Cybertrooper software application.  The
agreement  is  subject  to the approval of the Board of Directors of Datagility.
At  December  31,  2003,  no  binding  agreement  has  been  reached.

Revenues
========

Contract  revenues  rose  from  $158,524  in quarter ended September 30, 2003 to
$1,707,224  in  quarter  ending  December  31,  2003  which reflected increasing
activity  in  the  Lightec  business  and  pilot  implementations  of  eMedRx
application.  The  revenue  increased  by  $755,619  over  the same period ended
December  31,  2002.  This  increase largely reflects activity levels on certain
Lightec  contracts which are seasonal and may reduce activity later in the year,
particularly  in  the  calendar  third  quarter.

Current  Liabilities
====================

Amounts  due  to non-related parties increased from $686,782 at June 30, 2003 to
$1,055,113  at December 31, 2003.  This reflects liabilities incurred associated
with  the  Lightec  hardware  and  software  re-selling  business.  Lightec  has
negotiated  payment  arrangements  with  original  equipment  manufacturer (OEM)
suppliers  which  permits  a  deferral of payment until physical delivery of the
goods  to  Lightec's  clients which brings Lightec's cash payments position into
line  with  Lightec's cash receipts position.  At December 31, 2003, Lightec had
invoiced  the entire value of the liabilities accrued, had taken delivery of the
assets from the OEM but not delivered them to the end-customer and had therefore
not  recognized  them  as  revenue.


Liquidity  and  Capital  Resources
==================================

At  December  31,  2003,  shareholder  deficit  totaled $6,155,282.  The deficit
decreased  from  $6,814,397  at  June  30,  2003.

The  period  to  December  31,  2003  saw  significant  increased cash flow from
operations.  These  increases  reflect  significantly  increased  activity  and
revenues recognized from Lightec versus the period ending December 31, 2002.  We
believe  that  positive  cash flow from Lightec could have a significant role in
funding Security Biometrics as a whole for the remainder of the year.  It should
be  noted  that  a  total of 31.4% of gross cash receipts from Lightec contracts
with  the Bridgeport Board of Education are currently committed to servicing the
Notes  and  Convertible  Debentures  Payable  (see  Note  7  to  the  Financial
Statements).


                                       24
<PAGE>

Due  to  debt  service  obligations  and  the management's strategy to invest in
activities and operations that will provide long term strength to our liquidity,
we  do not believe that we will be cash flow positive over the short term and we
will  continue  to  need  additional  financing  from  sales  of stock and other
sources.  Should  this  be unattainable our ability to continue the operation of
these  businesses  and  expand  our  other  biometric security activities may be
severely  impaired.

For  the  six  month  period  ending  December  31,  2003 cash in-flows from the
issuance  of  stock  valued  at  $1,175,685.

Edinburgh LLC's convertible Debentures and Notes Payable to Maryanne Richard and
Synergex  Group  (a  related party) (see Note 7 to the Financial Statements) are
secured  by  the  assets of Lightec and required Security Biometrics to generate
significant  cash  flows  from  operations or financing to meet our obligations.
Cash  flows  could also be impaired on account of acceleration by Edinburgh LLC.

Off-Balance  Sheet  Arrangements
================================

We  have no off balance sheet arrangements that have or are reasonably likely to
have  a  current  or  future  effect  on  us  that  is  material  to  investors.


ITEM  3.          CONTROLS  AND  PROCEDURES.

An evaluation was performed, as of December 31st 2003, under the supervision and
with  the participation of our management, including our Chief Executive Officer
and Chief Financial Officer, of the effectiveness of the design and operation of
our  disclosure  controls  and  procedures.  Based  on  such  evaluation,  our
management  has  concluded  that our disclosure  controls  and  procedures  were
effective  as of December 31st , 2003. There have been no significant changes in
our  internal  controls  or  other factors that could  significantly  affect our
internal  controls  subsequent  to  December  31st,  2003.



PART  II

ITEM  1.             LEGAL  PROCEEDINGS.

A  settlement  was  reached in the amount $31,000 with David Alexander, a former
employee,  in  December  2003. The settlement was made in relation to a claim of
unpaid  salaries  and the Company recorded a gain on debt settlement of $35,139.

Edinburgh  LLC  contacted  us to notify us that the company was not in technical
compliance  with  stipulations  under  the  court  approved  settlement.  Such
requirements  are  currently  being  remedied.

Neither  we,  nor  any  of  our  subsidiaries,  is a party to any material legal
proceeding, nor, to our knowledge, is any material litigation threatened against
us  or  our  subsidiaries.

ITEM  2.     CHANGES  IN  SECURITIES.

During  the  three  months  period ending December 31, 2003, we issued 5,548,000
shares  of  our  common  stock  for  cash  proceeds of $440,753 from the private
placements.  We  believe  that  the  issuance  of  such  shares  did not require
registration  under  the  Securities  Act  of  1933,  as  amended,  pursuant  to
exemptions  available  under  the  provisions  of  Sections 4(2) and 4(6) of the
Securities  Act.

ITEM  3.           DEFAULTS  ON  SENIOR  SECURITIES.

See  Item  1.

ITEM  4.          SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS.

None

ITEM  5.         OTHER  INFORMATION.

None

ITEM  6.         EXHIBITS  AND  REPORTS  ON  FORM  8-K.


                                       25
<PAGE>

Exhibition  Description
Number


31.1     Certificate  of  Michel  Berty  pursuant  to  Section 302 of the
Sarbanes-Oxley  Act  2002

31.2     Certificate  of  William  Moore  pursuant  to Section 302 of the
Sarbanes-Oxley  Act  2002

32.1     Certificate  of  Michel  Berty  pursuant  to  18 U.S.C.1350, as adopted
pursuant  to  section  906  of  the  Sarbanes-Oxley  Act  of  2002.

32.2     Certificate  of  William  Moore  pursuant  to 18 U.S.C.1350, as adopted
pursuant  to  section  906  of  the  Sarbanes-Oxley  Act  of  2002.


(b)     Reports  on  Form  8-K

None

                                   SIGNATURES


In  accordance  with  Section  13  or 15 (d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                     By:  /s/  Michel  Berty
                                     -----------------------
                                     Name:  Michel  Berty
Date:  February 10th,  2004          Title: Chairman and Chief Executive Officer


                                     By:  /s/  William  Moore
                                     ------------------------
                                     Name:  William  Moore
Date:  February 10th  ,  2004        Title:  Chief  Financial  Officer


                                       26
<PAGE>